As a manufacturer based in China, I’m excited to present you our high-quality Cefcapene pivoxil, with the chemical structure C23H29N5O8S2 and CAS number 105889-45-0. This antibiotic is specifically designed to tackle a range of bacterial infections, making it an essential addition to your pharmaceutical product lineup. We take pride in producing Cefcapene pivoxil under strict quality controls, ensuring that each batch meets international standards. Our product offers great solubility and stability, making it effective for various formulations. Partnering with us not only guarantees you a reliable source of this potent antibiotic but also ensures you receive competitive pricing. Whether you’re looking to expand your product offerings or seeking a dependable supplier for your pharmaceutical needs, I am here to assist. Let's connect and explore how we can meet your requirements with our Cefcapene pivoxil.
In the fast-evolving pharmaceutical landscape, the compound Cefcapene pivoxil (CAS Number: 105889-45-0) stands out due to its significant potential in treating bacterial infections. This advanced cephalosporin derivative is characterized by its unique chemical structure, C23H29N5O8S2, which enhances its efficacy and safety profile. As global demand for innovative and effective antimicrobial agents grows, Cefcapene pivoxil is poised to become a key player, paving the way for healthcare advancements in 2025 and beyond. In the pursuit of innovative solutions, our focus remains on delivering high-quality pharmaceutical ingredients that meet the rigorous standards of global markets. The pharmaceutical industry is witnessing a shift toward more effective, patient-friendly formulations, and Cefcapene pivoxil is at the forefront of this change. Manufacturers looking to enhance their product portfolios can leverage the significant therapeutic benefits of this compound, contributing to better patient outcomes and addressing the pressing challenge of antibiotic resistance. As we look towards 2025, collaboration and innovation will be essential in overcoming the hurdles of the pharmaceutical sector. By investing in research and strategic partnerships, we can unlock the full potential of Cefcapene pivoxil. Global procurement managers and pharmaceutical companies seeking to strengthen their offerings should consider this compound as a viable option to meet evolving market demands while ensuring sustainability and efficacy in their production processes.
| Property | Value |
|---|---|
| Molecular Formula | C23H29N5O8S2 |
| CAS Number | 105889-45-0 |
| Molecular Weight | 545.65 g/mol |
| Solubility | Soluble in methanol and ethanol |
| Biological Half-Life | Approximately 3-4 hours |
| Administration Route | Oral administration |
| Indications | Treatment of respiratory tract infections |
| Year of Market Introduction | 2000 |
| Current Research Phase | Post-market surveillance |